MEDIFAST (MED)
(Delayed Data from NYSE)
$18.44 USD
+0.16 (0.88%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $18.46 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.44 USD
+0.16 (0.88%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $18.46 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Boston Beer's (SAM) Innovation and Expansion Plans on Track
by Zacks Equity Research
Boston Beer (SAM) continues to make solid brand-building and innovation efforts. It recently collaborates with Beam Suntory to expand into the spirits category.
B&G Foods (BGS) Poised on E-commerce Growth, Prudent Buyouts
by Zacks Equity Research
B&G Foods (BGS) is gaining on higher online sales. The company is actively pursuing strategic acquisitions to boost growth.
Kimberly-Clark (KMB) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter 2021 performance is likely to reflect softness in the K-C Professional unit and higher commodity costs. Nevertheless, saving efforts should offer some respite.
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Hain Celestial (HAIN) Boosts Brands With New Healthy Offerings
by Zacks Equity Research
Hain Celestial (HAIN) is launching several new products in snacks, teas and personal care.
General Mills' (GIS) Accelerate Strategy Bodes Well Amid High Costs
by Vrishali Bagree
General Mills (GIS) has been benefiting from its Accelerate strategy, which helps it make choices of how to win and where to play. However, management expects input cost inflation in fiscal 2022.
Things Worth Noting Before Philip Morris' (PM) Q2 Earnings
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2021 results are likely to reflect solid pricing power and strength in reduced risk products. However, duty-free business is likely to show weakness.
Conagra (CAG) Trims Guidance Despite Q4 Earnings & Sales Beat
by Vrishali Bagree
Conagra's (CAG) fourth-quarter fiscal 2021 earnings and sales decline year over year. Management expects increased cost inflation in fiscal 2022.
Tyson Foods (TSN) Rallies More Than 20% in a year: Here's Why
by Zacks Equity Research
Tyson Foods (TSN) is seeing robust growth in the retail business amid the pandemic. The company's focus on protein-packed brands is also yielding.
Zacks.com featured highlights include: Medifast, Builders FirstSource, C.H. Robinson Worldwide, Landstar System and AutoNation
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, Builders FirstSource, C.H. Robinson Worldwide, Landstar System and AutoNation
5 Top-Ranked Stocks That Have Emerged as DuPont Winners
by Sanghamitra Saha
Use the DuPont technique to pick solid profit-generating stocks like A, CHRW, BLDR, LSTR and MED.
Helen of Troy's (HELE) Q1 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) first-quarter fiscal 2022 results reflect growth in earnings and net sales on strength in all segments.
Conagra Brands (CAG) to Post Q4 Earnings: What to Expect?
by Zacks Equity Research
Conagra's (CAG) fourth-quarter fiscal 2021 results are likely to reflect softness in its Foodservice business. Pandemic-induced expenses and cost inflation remain other concerns.
Here's Why Lamb Weston (LW) Stock is Up More Than 30% in a Year
by Zacks Equity Research
Lamb Weston (LW) has been gaining on its robust Retail segment, alongside efficient price/mix and efforts to boost capacity.
Church & Dwight (CHD) Gains on Organic Sales Amid High Costs
by Zacks Equity Research
Church & Dwight (CHD) has been benefiting from solid organic sales and strong online sales amid the pandemic. However, escalated costs, including marketing spend, are a concern.
General Mills (GIS) Buys Pet Treats Business, Reshapes Portfolio
by Zacks Equity Research
General Mills (GIS) acquires Tyson Foods' pet treats business for $1.2 billion to fortify its Pet platform. The company takes over Tyson Foods' Independence, IA production unit.
Altria (MO) Up 14% in 6 Months, Gains on Low-Risk Products
by Zacks Equity Research
Altria's (MO) low-risk tobacco offerings such as IQOS and on! are gaining popularity. Moreover, strong pricing for tobacco products is an upside.
Service Corporation (SCI) Seems to be in a Good Spot: Here's Why
by Zacks Equity Research
Service Corporation (SCI) has been benefiting from greater operations amid the pandemic, which led to increased mortality. Also, solid cost control has been a driver.
Zacks.com featured highlights include: Digital Turbine, FedEx, Medifast and Tilly's
by Zacks Equity Research
Zacks.com featured highlights include: Digital Turbine, FedEx, Medifast and Tilly's
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Philip Morris (PM) to Boost Smoke-Free Options With Fertin Pharma
by Zacks Equity Research
Philip Morris (PM) is expected to complete the acquisition of Fertin Pharma by fourth-quarter fiscal 2021. The move is likely to help its innovation capabilities in the oral delivery platform.
4 Profitable Stocks Boasting Amazingly High Net Income Ratio
by Nitish Marwah
Net income ratio gives us the exact profitability level of a company. It reflects the percentage of net income to total sales revenues.
Zacks.com featured highlights include: Medifast, Vista Outdoor, International Paper and Hess Corp
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, Vista Outdoor, International Paper and Hess Corp
McCormick's (MKC) Q2 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
McCormick's (MKC) second-quarter fiscal 2021 results reflect the impact of higher sales driven by growth in the Flavor Solutions unit. Management raises fiscal 2021 view.
4 Top-Rated Efficient Stocks to Enrich Your Portfolio
by Tirthankar Chakraborty
MEDIFAST (MED), Vista Outdoor (VSTO), International Paper (IP) & Hess (HES) are the four top-ranked stocks that have a favorable efficiency level and are expected to provide stellar returns.